Vertebral fractures at hospitalization predict impaired respiratory function during follow-up of COVID-19 survivors
- 8 June 2022
- journal article
- research article
- Published by Springer Science and Business Media LLC in Endocrine
- Vol. 77 (2), 392-400
- https://doi.org/10.1007/s12020-022-03096-7
Abstract
Purpose Morphometric vertebral fractures (VFs) have been recently reported as an important component of the endocrine phenotype of COVID-19 and emerging data show negative respiratory sequelae at long-term follow-up in COVID-19 survivors. The aim of this study was to evaluate the impact of VFs on respiratory function in COVID-19 survivors. Methods We included patients referred to our Hospital Emergency Department and re-evaluated during follow-up. VFs were detected on lateral chest X-rays on admission using a qualitative and semiquantitative assessment and pulmonary function tests were obtained by Jaeger-MasterScreen-Analyzer Unit 6 months after discharge. Results Fifty patients were included. Median age was 66 years and 66% were males. No respiratory function data were available at COVID-19 diagnosis. VFs were detected in 16 (32%) patients. No differences between fractured and non-fractured patients regarding age and sex were observed. Although no difference was observed between VF and non-VF patient groups in the severity of pneumonia as assessed by Radiological-Assessment-of-Lung-Edema score at admission, (5 vs. 6, p = 0.69), patients with VFs were characterized as compared to those without VFs by lower Forced Vital Capacity (FVC, 2.9 vs. 3.6 L, p = 0.006; 85% vs. 110% of predicted, respectively, p = 0.001), Forced Expiratory Volume 1st s (FEV1, 2.2 vs. 2.8 L, p = 0.005; 92% vs. 110% of predicted, respectively, p = 0.001) and Diffusing Capacity of the Lungs for Carbon Monoxide (DLCO 5.83 vs. 6.98 mmol/min/kPa, p = 0.036, 59% vs. 86.3% of predicted, respectively, p = 0.043) at 6-month follow up. Conclusions VFs, expression of the endocrine phenotype of the disease, appear to influence medium-term impaired respiratory function of COVID-19 survivors which may significantly influence their recovery. Therefore, our findings suggest that a VFs assessment at baseline may help in identifying patients needing a more intensive respiratory follow-up and patients showing persistent respiratory impairment without evidence of pulmonary disease may benefit from VFs assessment to preventing the vicious circle of further fractures and respiratory deterioration.Keywords
This publication has 73 references indexed in Scilit:
- Risk of Major Osteoporotic Fracture After Cardiovascular Disease: A Population-Based Cohort Study in TaiwanJournal of Epidemiology, 2013
- The Effect of Vertebroplasty on Pulmonary Function in Patients With Osteoporotic Compression Fractures of the Thoracic SpineJournal of Spinal Disorders & Techniques, 2011
- Improvement in respiratory function after vertebroplasty and kyphoplastyInternational Orthopaedics, 2008
- Mechanisms of Anabolic Therapies for OsteoporosisThe New England Journal of Medicine, 2007
- Osteoporosis-Related Kyphosis and Impairments in Pulmonary Function: A Systematic ReviewJournal of Bone and Mineral Research, 2007
- Prognostic utility of a semiquantitative spinal deformity indexBone, 2005
- Evaluation of pulmonary function and quality of life in women with osteoporosisOsteoporosis International, 2005
- Vertebral fracture assessment using a semiquantitative techniqueJournal of Bone and Mineral Research, 1993
- Incidence of clinically diagnosed vertebral fractures: A population-based study in rochester, minnesota, 1985-1989Journal of Bone and Mineral Research, 1992
- Spirometric findings and mortality in never-smokersJournal of Clinical Epidemiology, 1990